Claar Advisors’s Precigen PGEN Stock Holding History

Claar Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,450	Closed	-$1.4M	–	29
2016 Q3	$1.4M	Hold	50,450	–	–	0.71%	20
2016 Q2	$1.23M	Hold	50,450	–	–	0.61%	20
2016 Q1	$1.7M	Hold	50,450	–	–	0.88%	15
2015 Q4	$1.51M	Hold	50,450	–	–	0.96%	15
2015 Q3	$1.59M	Sell	50,450 -61,661	-55%	-$3.01M	0.87%	20
2015 Q2	$5.42M	Sell	112,111 -4,148	-4%	-$175K	2.14%	18
2015 Q1	$5.04M	Sell	116,259 -94,170	-45%	-$3.38M	2.02%	17
2014 Q4	$5.54M	Hold	210,429	–	–	2.08%	20
2014 Q3	$3.74M	Hold	210,429	–	–	1.36%	23
2014 Q2	$5.05M	Buy	210,429 +94,170	+81%	+$1.91M	1.74%	22
2014 Q1	$2.92M	Buy	+116,259	New	+$3.22M	1.17%	25

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Claar Advisors's PGEN Position: Q4 2016 in Review

Claar Advisors sold out of Precigen (PGEN) in Q4 2016, closing a stake of 50,450 shares — an estimated $1.4M sold.

Claar Advisors first reported a position in PGEN in Q1 2014 and held it in 11 quarters. The position peaked at $5.54M in Q4 2014. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

Claar Advisors reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
Claar Advisors sold 50,450 Precigen shares in Q4 2016, an estimated $1.4M.
Claar Advisors first reported a position in Precigen in Q1 2014 and held it in 11 quarters.
Claar Advisors's Precigen position peaked at $5.54M in Q4 2014.
171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Claar Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.